Close
Close
Treatment Database
flunarizine
Trade Name not avaiable
Orphan Indication Alternating Hemiplegia
USA Market Approval
USA Designation Date 20-11-2018
Sponsor Xenon Pharmaceuticals, Inc.
200-3650 Gilmore Way
Burnaby, British Columbia
More about Alternating hemiplegia of childhood
Free Newsletter
Related Videos
by Abidemi Uruejoma
3,357 views